In addition, CTD-ILD patients, but not IPF patients, exhibited significantly higher level of serum Rcn3 than controls, suggesting that Rcn3 could be more sensitive to immune-inflammatory interstitial changes. Here, RCN3 is linked to interstitial lung disease.